Methylglyoxal-derived hydroimidazolone-1 evokes inflammatory reactions in endothelial cells via an interaction with receptor for advanced glycation end products

被引:27
作者
Ishibashi, Yuji [1 ]
Matsui, Takanori [1 ]
Nakamura, Nobutaka [1 ]
Sotokawauchi, Ami [1 ]
Higashimoto, Yuichiro [2 ]
Yamagishi, Sho-ichi [1 ]
机构
[1] Kurume Univ, Sch Med, Dept Pathophysiol & Therapeut Diabet Vasc Complic, Kurume, Fukuoka 8300011, Japan
[2] Kurume Univ, Sch Med, Dept Chem, Kurume, Fukuoka, Japan
关键词
Methylglyoxal-derived hydroimidazolone 1; receptor for advanced glycation end products; inflammation; endothelial cells; CARDIOVASCULAR-DISEASE; AGES; APTAMERS; DAMAGE;
D O I
10.1177/1479164117715855
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Glyceraldehyde-derived advanced glycation end products contribute to vascular inflammation in diabetes. However, what advanced glycation end product structure could evoke inflammatory reactions remains unknown. We examined whether and how methylglyoxal-derived hydroimidazolone 1, one of the advanced glycation end products formed from glyceraldehyde, elicits inflammatory reactions in human umbilical vein endothelial cells. Materials and methods: Glyceraldehyde-advanced glycation end products-aptamer was prepared using a systemic evolution of ligands by exponential enrichment. The binding affinities of methylglyoxal-derived hydroimidazolone 1 to receptor for advanced glycation end products or advanced glycation end product-aptamer were measured with a quartz crystal microbalance. Intracellular reactive oxygen species generation and THP-1 cell adhesion were evaluated using fluorescent probes. Gene expression was analysed by reverse transcription polymerase chain reaction. Results: Methylglyoxal-derived hydroimidazolone 1 bound to receptor for advanced glycation end products and advanced glycation end product-aptamer with a dissociation constant (Kd) of 56.7 mu M and 1.51 mM, respectively. Methylglyoxal-derived hydroimidazolone 1 at 100 ae g/mL significantly increased reactive oxygen species generation in human umbilical vein endothelial cells, which were attenuated by anti-receptor for advanced glycation end products antibody or advanced glycation end product-aptamer. In all, 100 mu g/mL methylglyoxal-derived hydroimidazolone 1 significantly increased receptor for advanced glycation end products and intercellular adhesion molecule-1 messenger RNA levels in, and THP-1 cell adhesion to, human umbilical vein endothelial cells, all of which were blocked by anti-receptor for advanced glycation end products antibody. Conclusion: Our present results indicate that methylglyoxal-derived hydroimidazolone 1 evokes inflammatory reactions in human umbilical vein endothelial cells via receptor for advanced glycation end products, although apparently limited to supraphysiological levels of methylglyoxal-derived hydroimidazolone 1. Methylglyoxal-derived hydroimidazolone 1 is a distinct advanced glycation end product structure that could mediate harmful effects of methylglyoxal and glyceraldehyde-mediated glycation processes.
引用
收藏
页码:450 / 453
页数:4
相关论文
共 16 条
[1]   Profound mishandling of protein glycation degradation products in uremia and dialysis [J].
Agalou, S ;
Ahmed, N ;
Babaei-Jadidi, R ;
Dawnay, A ;
Thornalley, PJ .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (05) :1471-1485
[2]   Peptide mapping identifies hotspot site of modification in human serum albumin by methylglyoxal involved in ligand binding and esterase activity [J].
Ahmed, N ;
Dobler, D ;
Dean, M ;
Thornalley, PJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (07) :5724-5732
[3]   Glyoxalase-1 overexpression reduces endothelial dysfunction and attenuates early renal impairment in a rat model of diabetes [J].
Brouwers, Olaf ;
Niessen, Petra M. G. ;
Miyata, Toshio ;
Ostergaard, Jakob A. ;
Flyvbjerg, Allan ;
Peutz-Kootstra, Carine J. ;
Sieber, Jonas ;
Mundel, Peter H. ;
Brownlee, Michael ;
Janssen, Ben J. A. ;
De Mey, Jo G. R. ;
Stehouwer, Coen D. A. ;
Schalkwijk, Casper G. .
DIABETOLOGIA, 2014, 57 (01) :224-235
[4]   Blockade by phosphorothioate aptamers of advanced glycation end products-induced damage in cultured pericytes and endothelial cells [J].
Higashimoto, Yuichiro ;
Matsui, Takanori ;
Nishino, Yuri ;
Taira, Junichi ;
Inoue, Hiroyoshi ;
Takeuchi, Masayoshi ;
Yamagishi, Sho-ichi .
MICROVASCULAR RESEARCH, 2013, 90 :64-70
[5]   The role of AGEs in cardiovascular disease [J].
Jandeleit-Dahm, Karin ;
Cooper, Mark E. .
CURRENT PHARMACEUTICAL DESIGN, 2008, 14 (10) :979-986
[6]   Sulforaphane reduces advanced glycation end products (AGEs)-induced inflammation in endothelial cells and rat aorta [J].
Matsui, T. ;
Nakamura, N. ;
Ojima, A. ;
Nishino, Y. ;
Yamagishi, S. -i. .
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2016, 26 (09) :797-807
[7]   Glyceraldehyde-derived pyridinium (GLAP) evokes oxidative stress and inflammatory and thrombogenic reactions in endothelial cells via the interaction with RAGE [J].
Matsui, Takanori ;
Oda, Eriko ;
Higashimoto, Yuichiro ;
Yamagishi, Sho-ichi .
CARDIOVASCULAR DIABETOLOGY, 2015, 14
[8]   Vildagliptin blocks vascular injury in thoracic aorta of diabetic rats by suppressing advanced glycation end product-receptor axis [J].
Matsui, Takanori ;
Nishino, Yuri ;
Takeuchi, Masayoshi ;
Yamagishi, Sho-ichi .
PHARMACOLOGICAL RESEARCH, 2011, 63 (05) :383-388
[9]   Circulating advanced glycation end products (AGEs) and soluble form of receptor for AGEs (sRAGE) are independent determinants of serum monocyte chemoattractant protein-1 (MCP-1) levels in patients with type 2 diabetes [J].
Nakamura, Kazuo ;
Yamagishi, Sho-ichi ;
Adachi, Hisashi ;
Matsui, Takanori ;
Kurita-Nakamura, Yayoi ;
Takeuchi, Masayoshi ;
Inoue, Hiroyoshi ;
Imaizumi, Tsutomu .
DIABETES-METABOLISM RESEARCH AND REVIEWS, 2008, 24 (02) :109-114
[10]   The diverse ligand repertoire of the receptor for advanced glycation endproducts and pathways to the complications of diabetes [J].
Ramasamy, Ravichandran ;
Yan, Shi Fang ;
Schmidt, Ann Marie .
VASCULAR PHARMACOLOGY, 2012, 57 (5-6) :160-167